Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment
about
PPARγ in Bacterial Infections: A Friend or Foe?Clearance of apoptotic neutrophils and resolution of inflammation.Advances in clinical immunology in 2015.The immune response to secondary necrotic cells.Noninfectious Manifestations and Complications of Chronic Granulomatous Disease.Impaired efferocytosis by monocytes in multiple myeloma.
P2860
Impaired efferocytosis in human chronic granulomatous disease is reversed by pioglitazone treatment
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Impaired efferocytosis in huma ...... rsed by pioglitazone treatment
@ast
Impaired efferocytosis in huma ...... rsed by pioglitazone treatment
@en
type
label
Impaired efferocytosis in huma ...... rsed by pioglitazone treatment
@ast
Impaired efferocytosis in huma ...... rsed by pioglitazone treatment
@en
prefLabel
Impaired efferocytosis in huma ...... rsed by pioglitazone treatment
@ast
Impaired efferocytosis in huma ...... rsed by pioglitazone treatment
@en
P2093
P2860
P1476
Impaired efferocytosis in huma ...... rsed by pioglitazone treatment
@en
P2093
Beatriz E Marciano
Christa S Zerbe
Donna L Bratton
Emilia Liana Falcone
Peter M Henson
Ruby F Fernandez-Boyanapalli
S Courtney Frasch
Steven M Holland
P2860
P304
1399-1401.e3
P356
10.1016/J.JACI.2015.07.034
P407
P577
2015-09-17T00:00:00Z